Intuitive Surgical, Inc. $ISRG Shares Sold by Candriam S.C.A.

Candriam S.C.A. lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 270,080 shares of the medical equipment provider’s stock after selling 63,466 shares during the period. Intuitive Surgical accounts for approximately 0.6% of Candriam S.C.A.’s investment portfolio, making the stock its 29th biggest position. Candriam S.C.A. owned about 0.08% of Intuitive Surgical worth $120,788,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Norges Bank purchased a new position in Intuitive Surgical during the second quarter worth approximately $2,569,260,000. Rakuten Investment Management Inc. purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth $388,436,000. Vanguard Group Inc. boosted its position in shares of Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after acquiring an additional 670,302 shares during the last quarter. Jennison Associates LLC grew its holdings in shares of Intuitive Surgical by 20.4% in the second quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock valued at $1,696,738,000 after purchasing an additional 528,359 shares during the period. Finally, Bessemer Group Inc. increased its position in Intuitive Surgical by 89.3% during the second quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock worth $428,386,000 after purchasing an additional 371,806 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Gary S. Guthart sold 24,500 shares of the firm’s stock in a transaction dated Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the sale, the director owned 3,694 shares of the company’s stock, valued at approximately $1,958,189.40. This trade represents a 86.90% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Myriam Curet sold 230 shares of the company’s stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $532.61, for a total value of $122,500.30. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 70,011 shares of company stock worth $38,858,275. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Up 2.5%

NASDAQ ISRG opened at $488.15 on Monday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $609.08. The firm has a 50 day moving average of $549.63 and a two-hundred day moving average of $510.60. The stock has a market capitalization of $173.36 billion, a PE ratio of 61.87, a price-to-earnings-growth ratio of 3.79 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company’s revenue was up 18.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.21 earnings per share. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several analyst reports. Argus dropped their price target on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research note on Wednesday, February 4th. HSBC increased their price objective on Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a research report on Monday, January 26th. Leerink Partners lifted their target price on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Truist Financial increased their price target on Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a report on Thursday, December 18th. Finally, BTIG Research reissued a “buy” rating and set a $616.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 23rd. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $617.23.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.